3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Breast
1
Conditions
Lung Neoplasms
3
Respiratory Aspiration
1
Radiation Pneumonitis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Lymphangioleiomyomatosis
1
Head and Neck Neoplasms
1
Deglutition Disorders
1
Central Nervous System Neoplasms
1
Breast Neoplasms
1
Interventions
nintedanib
2
durvalumab
2
Radiotherapy
2
Immunotherapy
2
tislelizumab
1
sugemalimab
1
sintilimab
1
pembrolizumab
1
camrelizumab
1
beclomethasone 17-monopropionate
1
aumolertinib
1
atezolizumab
1
apatinib
1
Tomography, Emission-Computed, Single-Photon
1
Surveys and Questionnaires
1
Respiratory Function Tests
1
Prednisone
1
Nivolumab
1
Nicorandil
1
Immunoglobulin G
1
Immune Checkpoint Inhibitors
1
Hyperbaric Oxygenation
1
Esophagectomy
1
Disulfides
1
Dexamethasone
1
Cisplatin
1
Breath Holding
1
Angiogenesis Inhibitors
1
Adrenal Cortex Hormones
1
Adjuvants, Immunologic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Radiation Pneumonitis
×
Respiratory Function Tests
×
Clear all
NCT02735746
2025-08-22
HFFLI
Cedars-Sinai Medical Center
Completed
60 enrolled